HEPHAISTOS-Pharma Raises €4.5 Million to Revolutionize Cancer Treatment
HEPHAISTOS-Pharma, a biotech firm that focuses on developing cutting-edge immunotherapies to combat cancer by enhancing the body's innate immune response, has successfully concluded its seed funding round, raising a remarkable…